Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies

BACKGROUND: Peritoneal mesothelioma (PeM) is a rare malignancy with a poor prognosis. Currently there is a lack of effective systemic therapies. Due to the rarity of PeM, it is challenging to study new treatment options. Off-label use of targeted drugs could be an effective approach. This scoping re...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietz, M.V., van Kooten, J.P., Paats, M.S., Aerts, J.G.V.J., Verhoef, C., Madsen, E.V.E., Dubbink, H.J., von der Thüsen, J.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368826/
https://www.ncbi.nlm.nih.gov/pubmed/37453150
http://dx.doi.org/10.1016/j.esmoop.2023.101600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368826/
https://www.ncbi.nlm.nih.gov/pubmed/37453150
http://dx.doi.org/10.1016/j.esmoop.2023.101600

Ejemplares similares